Levothyroxine Amdipharm Limited (Levothyroxine Sodium)

Levothyroxine sodium is a synthetic form of thyroxine (T4). After oral absorption, it is converted to the active hormone triiodothyronine (T3) in peripheral tissues. Both T4 and T3 bind nuclear thyroid hormone receptors, regulating gene expression that controls metabolism, growth, and development, ultimately restoring normal thyroid function.

The appropriate dose is individualized and determined by the prescribing clinician based on the patient’s age, weight, cardiac status, and serial thyroid function tests (TSH and free T4). No fixed regimen is provided here; the prescriber will adjust the dose to achieve a euthyroid state.

Levothyroxine is classified as a pregnancy‑category drug where the benefits usually outweigh potential risks. Maintaining adequate thyroid hormone levels is essential for fetal development, so treatment is often continued with dose adjustments as needed. Limited data are available for breastfeeding, but small amounts may be secreted in milk; clinicians should evaluate risk‑benefit for each mother.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then respond with pricing, availability, shipping details (including any cold‑chain requirements) and required import documentation.

Levothyroxine provides the pro‑hormone T4, which the body converts to the active T3 as needed, offering a stable and predictable pharmacokinetic profile. Alternatives such as liothyronine (synthetic T3) act directly but have a shorter half‑life and may cause more rapid fluctuations in hormone levels. Combination therapy (T4 + T3) is sometimes used, but levothyroxine alone remains the standard first‑line treatment for most patients.

Store the tablets at temperatures below 25 °C in the original container, protecting them from moisture, heat and direct sunlight. Do not store in bathrooms or near kitchen appliances. Keep out of reach of children and ensure the packaging remains sealed until use.

Levothyroxine Amdipharm is taken orally, usually on an empty stomach, at least 30 minutes before breakfast with a full glass of water. Swallow the tablet whole; do not crush or chew. Consistency in timing and relation to meals helps maintain stable absorption.

Serious adverse events include cardiac arrhythmias, angina pectoris, and exacerbation of osteoporosis, particularly when the dose exceeds physiological requirements. Patients should be monitored for signs of overtreatment such as rapid heart rate, chest pain, bone pain, or unexplained fractures, and dose adjustments should be made promptly.

Levothyroxine is contraindicated in patients with untreated adrenal insufficiency, acute myocardial infarction, or uncorrected thyrotoxicosis. Individuals with known hypersensitivity to levothyroxine sodium or any excipients in the tablet should also avoid its use. Clinicians must assess each patient’s medical history before initiating therapy.